Multiple sclerosis tertiary prevention: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
==Tertiary Prevention== | ==Tertiary Prevention== | ||
The [[drugs]] which are used to treat [[MS]] can reduce the progression of the [[disease]] and delay [[disability]] occurrence but cannot stop the [[disease]]. Finally [[Disability|disabilities]] appear so controlling them can be beneficial in increasing [[MS]] [[patients]]’ [[quality of life]].<ref name="pmid16168933">{{cite journal |author=Kesselring J, Beer S |title=Symptomatic therapy and neurorehabilitation in multiple sclerosis |journal=Lancet neurology |volume=4 |issue=10 |pages=643–52 |year=2005 |pmid=16168933|doi=10.1016/S1474-4422(05)70193-9}}</ref> | The [[drugs]] which are used to treat [[MS]] can reduce the progression of the [[disease]] and delay [[disability]] occurrence but cannot stop the [[disease]]. Finally [[Disability|disabilities]] appear so controlling them can be beneficial in increasing [[MS]] [[patients]]’ [[quality of life]].<ref name="pmid16168933">{{cite journal |author=Kesselring J, Beer S |title=Symptomatic therapy and neurorehabilitation in multiple sclerosis |journal=Lancet neurology |volume=4 |issue=10 |pages=643–52 |year=2005 |pmid=16168933|doi=10.1016/S1474-4422(05)70193-9}}</ref> There is strong evidence that [[exercise]] therapy can improve [[muscle]] function and [[mobility]] in multiple sclerosis patients. | ||
===Spasticity=== | ===Spasticity=== | ||
There are also [[palliative]] measures like [[casting]]s, [[splint (medical)|splints]] or customised seatings.<ref name="isbn = 1 86016 182 0">{{cite book | last = The Royal College of Physicians |title = Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care | publisher = Sarum ColourView Group | date = 2004 | location = Salisbury, Wiltshire | isbn = 1 86016 182 0}}[http://www.rcplondon.ac.uk/pubs/books/MS/MSfulldocument.pdf Free full text] ([[2004-08-13]]). Retrieved on [[2007-10-01]].</ref> | There are also [[palliative]] measures like [[casting]]s, [[splint (medical)|splints]] or customised seatings.<ref name="isbn = 1 86016 182 0">{{cite book | last = The Royal College of Physicians |title = Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care | publisher = Sarum ColourView Group | date = 2004 | location = Salisbury, Wiltshire | isbn = 1 86016 182 0}}[http://www.rcplondon.ac.uk/pubs/books/MS/MSfulldocument.pdf Free full text] ([[2004-08-13]]). Retrieved on [[2007-10-01]].</ref> |
Revision as of 18:14, 4 March 2018
Multiple sclerosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Multiple sclerosis tertiary prevention On the Web |
American Roentgen Ray Society Images of Multiple sclerosis tertiary prevention |
Risk calculators and risk factors for Multiple sclerosis tertiary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tertiary Prevention
The drugs which are used to treat MS can reduce the progression of the disease and delay disability occurrence but cannot stop the disease. Finally disabilities appear so controlling them can be beneficial in increasing MS patients’ quality of life.[1] There is strong evidence that exercise therapy can improve muscle function and mobility in multiple sclerosis patients.
Spasticity
There are also palliative measures like castings, splints or customised seatings.[2]
Tremors and Ataxia
Physical therapy is not indicated as a treatment for tremor or ataxia; however, the use of different orthese devices can help. An example is the use of wrist bandages with weights, which can be useful to increase the inertia of movement and therefore reduce tremor.[3] Daily use objects have also to be adapted so they are easier to grab and use.
References
- ↑ Kesselring J, Beer S (2005). "Symptomatic therapy and neurorehabilitation in multiple sclerosis". Lancet neurology. 4 (10): 643–52. doi:10.1016/S1474-4422(05)70193-9. PMID 16168933.
- ↑ The Royal College of Physicians (2004). Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care. Salisbury, Wiltshire: Sarum ColourView Group. ISBN 1 86016 182 0.Free full text (2004-08-13). Retrieved on 2007-10-01.
- ↑ Aisen ML, Arnold A, Baiges I, Maxwell S, Rosen M (1993). "The effect of mechanical damping loads on disabling action tremor". Neurology. 43 (7): 1346–50. PMID 8327136.